Research Topics
| W P OlszynskiSummaryCountry: Canada Publications
| Collaborators
|
Detail Information
Publications
Evaluation of easily measured risk factors in the prediction of osteoporotic fracturesRobert Bensen
Medical Science, McMaster University, Hamilton, Ontario, Canada
BMC Musculoskelet Disord 6:47. 2005..As few premonitory symptoms for fracture exist, it is of critical importance that physicians effectively and efficiently identify individuals at increased fracture risk...
Alendronate for the treatment of osteoporosis in menW P Olszynski
University of Saskatchewan, Saskatoon, SK, Canada
Expert Opin Pharmacother 9:491-8. 2008..Men have higher rates of osteoporosis and suffer fragility fractures more often than previously believed. Fracture-related morbidity and mortality in men is substantially higher than in women...- Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational studyW P Olszynski
Saskatoon Osteoporosis Centre, Saskatoon, SK, S7K 0H6, Canada
Osteoporos Int 17:217-24. 2006..The effect of these two bisphosphonates on fractures and FN BMD in osteoporotic men is likely positive, but requires further study... - Osteoporosis in men: epidemiology, diagnosis, prevention, and treatmentWojciech P Olszynski
Department of Medicine, University of Saskatchewan, Saskatoon Osteoporosis Centre, Saskatoon, Saskatchewan, Canada
Clin Ther 26:15-28. 2004..Osteoporosis and fragility fractures in men account for substantial health care expenditures and decreased quality of life... - The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)J D Adachi
Department of Medicine, St Joseph s Hospital, McMaster University, Charlton Avenue East, Suite 501, L8 N 1Y2 Hamilton, Ontario, Canada
Osteoporos Int 14:895-904. 2003..06; 95% CI: -0.11, -0.00) for women, and rib fractures (-0.06; 95% CI: -0.12, -0.00) for men. In conclusion, this study demonstrates a negative association between osteoporotic fractures and quality of life in both women and men... 
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohortsW D Leslie
Department of Medicine, University of Manitoba, Winnipeg, MB, Canada
Osteoporos Int 22:1873-83. 2011..A procedure for creating a simplified version of fracture risk assessment tool (FRAX®) is described. Calibration, fracture prediction, and concordance were compared with the full FRAX tool using two large, complementary Canadian datasets...- Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis StudyD A Hanley
Department of Medicine, University of Calgary Calgary, Alberta, Canada
J Bone Miner Res 18:784-90. 2003..The importance of these associations for osteoporosis case finding and management require further and prospective studies... - The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trialMark Lemstra
College of Medicine, University of Saskatchewan, Saskatoon, Canada
Clin J Pain 21:166-74. 2005..CONCLUSIONS: Positive health-related outcomes in this mostly unresponsive condition can be obtained with a low-cost, group multidisciplinary intervention in a community-based, nonclinical setting... - Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi
Department of Medicine, St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada
Aging (Milano) 13:347-54. 2001..These results are consistent with, and complement those from previous studies showing that risedronate 5 mg has a gastrointestinal tolerability similar to that of placebo... - The influence of motor vehicle legislation on injury claim incidenceMark Lemstra
College of Medicine, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK S7N 0W8
Can J Public Health 96:65-8. 2005..Legislative system and injury compensation scheme have an observable impact on injury claim incidence and can therefore have significant impact on the health care system... - Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis IndexW P Maksymowych
Department of Medicine, University of Alberta, Canada
Ann Rheum Dis 68:948-53. 2009..Enthesitis is a recommended core domain for assessment of ankylosing spondylitis (AS), but no measurement has yet been validated according to Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) criteria... - The effectiveness of standard care, early intervention, and occupational management in Workers' Compensation claims: part 2Mark Lemstra
College of Medicine, University of Saskatchewan, Saskatoon, Canada
Spine 29:1573-9. 2004..67, 95% confidence interval 1.05-27.20). CONCLUSIONS: It is recommended that an occupational management approach, in comparison to early intervention treatment and standard care, be considered for management of occupational injuries... - Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?Anna M Sawka
McMaster University, St Joseph s Healthcare, Centre for Evaluation of Medicines, Hamilton, Ontario, Canada
J Rheumatol 31:1993-5. 2004..To determine if there are differences between men and women referred for treatment of osteoporosis in Canada... - Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agentsClaudie Berger
CaMos Methods Centre, McGill University, Montreal, Que
CMAJ 178:1660-8. 2008..We sought to estimate the average rate of change in bone mineral density as a function of age among Canadians aged 25-85, stratified by sex and use of antiresorptive agents... - Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its useAnthony B Hodsman
University of Western Ontario, St Joseph s Health Care, Room 2F 15, 268, Grosvenor Street, London, Ontario N6A 4V2, Canada
Endocr Rev 26:688-703. 2005..At present, concurrent therapy with antiresorptive therapy, particularly bisphosphonates, should be avoided, although sequential therapy with such agents may consolidate the beneficial effects upon the skeleton after PTH is discontinued... - Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?Anna M Sawka
Department of Medicine, St Joseph s Healthcare and McMaster University, Hamilton ON
J Obstet Gynaecol Can 27:759-64. 2005.... - Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO databaseAlexandra Papaioannou
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Osteoporos Int 14:808-13. 2003..In conclusion, alendronate users were more likely to discontinue therapy than etidronate users over the follow-up period. Potential barriers to long-term patient adherence to osteoporosis therapies need to be evaluated... - What predicts early fracture or bone loss on bisphosphonate therapy?Anna M Sawka
McMaster University, Hamilton, ON, CA
J Clin Densitom 6:315-22. 2003..13, 0.62, p = 0.002). In conclusion, early fracture on bisphosphonate therapy is most strongly predicted by a previous history of fracture and early bone loss is most strongly predicted by the potency of the prescribed bisphosphonate... - Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)Alexandra Papaioannou
Department of Medicine, St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada
Osteoporos Int 16:568-78. 2005..Furthermore, various anthropometric measures, disease conditions, and medications are associated with a new fracture. Identifying postmenopausal women at risk is important given that fracture prevention therapies are now available... - Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and childrenAliya A Khan
Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, ON, Canada
J Clin Densitom 7:51-64. 2004..Previously, this group addressed the performance of densitometry in postmenopausal women. This report addresses the use of densitometry in men, premenopausal women, and children with a focus on dual-energy X-ray absorptiometry... - Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official PositionsMarc Antoine Krieg
Lausanne University Hospital, Lausanne, Switzerland
J Clin Densitom 11:163-87. 2008..The ISCD Official Positions on QUS resulting from this PDC, the rationale for their establishment, and recommendations for further study are presented here... - The 2002 Canadian bone densitometry recommendations: take-home messagesAliya A Khan
Division of Geriatrics, McMaster University, Hamilton, ON
CMAJ 167:1141-5. 2002 - Management of osteoporosis in men: an update and case exampleAliya A Khan
Division of Endocrinology and Geriatrics, Department of Medicine, McMaster University, Hamilton, Ont
CMAJ 176:345-8. 2007..The current paper supplements that guideline and provides a review and synthesis of the current literature on the diagnosis and management of osteoporosis in men... - Bone strength: the whole is greater than the sum of its partsK Shawn Davison
Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
Semin Arthritis Rheum 36:22-31. 2006..To summarize the current knowledge regarding the various determinants of bone strength... - The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the futureK Shawn Davison
Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
Semin Arthritis Rheum 36:10-21. 2006..To summarize the current knowledge regarding the impact of the most common antifracture medications on the various determinants of bone strength... - Standards for performing DXA in individuals with secondary causes of osteoporosisAliya A Khan
Division of Endocrinology, McMaster University, Hamilton, Ontario, Canada, and Hanover General Hospital, PA, USA
J Clin Densitom 9:47-57. 2006..Dual-energy X-ray absorptiometry is a valuable tool in assessing skeletal health in individuals with secondary causes of osteoporosis...